Showing results (11-20 of 16) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Experimental Hematology & Oncology|March 26, 2024
Cyclin dependent kinase 4/6 inhibitor palbociclib synergizes with BCL2 inhibitor venetoclax in experimental models of mantle cell lymphoma without RB1 deletionDiana Malarikova, Radek Jorda, Kristyna Kupcova, et al.Cell Death Discovery|February 18, 2025
Long-term adaptation of lymphoma cell lines to hypoxia is mediated by diverse molecular mechanisms that are targetable with specific inhibitorsLenka Daumova, Dmitry Manakov, Jiri Petrak, et al.Blood Advances|September 14, 2020
Targeting phosphatidylinositol 3 kinase-β and -δ for Bruton tyrosine kinase resistance in diffuse large B-cell lymphomaNeeraj Jain, Satishkumar Singh, Georgios Laliotis, et al.British Journal of Haematology|September 8, 2025
Circulating tumour DNA as a predictor of survival of patients with diffuse large B-cell lymphoma in a daily practiceProkop Vodicka, Iva Hamova, Adriana Velasova, et al.The Journal of Experimental Medicine|March 21, 2024
Antigen-independent, autonomous B cell receptor signaling drives activated B cell DLBCLJanneke A Eken, Marvyn T Koning, Kristyna Kupcova, et al.Cancer Research|October 9, 2021
Inhibition of PIM Kinases in DLBCL Targets MYC Transcriptional Program and Augments the Efficacy of Anti-CD20 AntibodiesMaciej Szydłowski, Filip Garbicz, Ewa Jabłońska, et al.Pageof 2